This article seeks to summarize what Brexit could mean for the U.K. and EU pharmaceutical and medical device sectors.
The U.K. government is expected to invoke Article 50 of the Lisbon Treaty by notifying the EU Council of its intention to leave the EU in early 2017. If no agreement is reached within two years of the notification, then EU laws cease to apply in the U.K. The two-year period may only be extended if the European Council unanimously agrees.